10X Genomics (TXG) PT Lowered to $60 at Morgan Stanley
Tweet
Share
E-mailGet Alerts TXG Hot Sheet
Price: $56.09 -3.54%
Rating Summary:
7 Buy, 11 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
7 Buy, 11 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Morgan Stanley analyst Tejas Savant lowered the price target on 10X Genomics (NASDAQ: TXG) to $60.00 (from $65.00) while maintaining a Overweight rating.
You May Also Be Interested In
- 10X Genomics (TXG) PT Raised to $65 at Stephens
- Va Tech Wabag Ltd. (VATW:IN) PT Raised to INR2,410 at ICICI Securities
- Diversified Royalty Corp (DIV:CN) (BEVFF) PT Lowered to Cdn$4.75 at Desjardins
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
